Gregory Howard

Gregory Howard serves as a Clinical Trial Manager at the University of East Anglia (UEA), affiliated with Norwich Medical School, Population Health, and the Norwich Clinical Trials Unit. He holds a PhD in Psychology from UEA (2017) and completed his MSc in Child and Family Psychology at UEA in 2011, following a BA in Psychology from the University of Mississippi (2010). His research focuses on clinical trials in public health, preventive medicine, and oncology care. Key projects include the BabyBreathe trial (postpartum smoking cessation) and studies on biomarkers in dementia. His recent publications emphasize clinical trial methodologies, e-consent protocols, and exercise interventions in cancer recovery.

• Education: BA Psychology (2010), MSc Child & Family Psychology (2011), PhD Psychology (2017)

Research interests span clinical trial design, behavioral health interventions, and healthcare ethics. Collaborations include work on dementia biomarkers and colorectal cancer rehabilitation. He has contributed to six articles and one comment/debate piece since 2021, with notable focus on trial protocols and patient-centered care.

His work includes multidisciplinary projects funded by the National Institute for Health and Alzheimer’s Research UK. No scientific awards are explicitly mentioned, but his contributions to trial methodologies are highlighted through peer-reviewed outputs. He is part of the Norwich CTU Methodology Group and collaborates with institutions across the UK.